State of Wisconsin Investment Board’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-163,290
| Closed | -$21.5M | – | 2441 |
|
|
2025
Q1 | $21.5M | Buy |
163,290
+89,276
| +121% | +$11.1M | 0.06% | 303 |
|
|
2024
Q4 | $6.18M | Sell |
74,014
-4,042
| -5% | -$332K | 0.02% | 862 |
|
|
2024
Q3 | $5.71M | Sell |
78,056
-27,500
| -26% | -$2.07M | 0.01% | 894 |
|
|
2024
Q2 | $7.23M | Buy |
105,556
+9,470
| +10% | +$657K | 0.02% | 768 |
|
|
2024
Q1 | $6.65M | Buy |
96,086
+27,135
| +39% | +$1.86M | 0.02% | 846 |
|
|
2023
Q4 | $4.94M | Sell |
68,951
-1,452
| -2% | -$83.5K | 0.01% | 985 |
|
|
2023
Q3 | $3.67M | Sell |
70,403
-2,320
| -3% | -$135K | 0.01% | 1059 |
|
|
2023
Q2 | $4.6M | Sell |
72,723
-3,959
| -5% | -$247K | 0.01% | 996 |
|
|
2023
Q1 | $4.15M | Sell |
76,682
-8,610
| -10% | -$416K | 0.01% | 1062 |
|
|
2022
Q4 | $4.51M | Buy |
85,292
+61
| +0.1% | +$3.06K | 0.01% | 992 |
|
|
2022
Q3 | $3.97M | Sell |
85,231
-3,443
| -4% | -$180K | 0.01% | 1058 |
|
|
2022
Q2 | $5.06M | Sell |
88,674
-17,026
| -16% | -$965K | 0.01% | 986 |
|
|
2022
Q1 | $6.47M | Buy |
105,700
+5,900
| +6% | +$306K | 0.01% | 1026 |
|
|
2021
Q4 | $5.22M | Sell |
99,800
-1,000
| -1% | -$42K | 0.01% | 1024 |
|
|
2021
Q3 | $3.76M | Sell |
100,800
-100
| -0.1% | -$3.48K | 0.01% | 1122 |
|
|
2021
Q2 | $4.12M | Hold |
100,900
| – | – | 0.01% | 1105 |
|
|
2021
Q1 | $3.42M | Sell |
100,900
-2,400
| -2% | -$83.3K | 0.01% | 1123 |
|
|
2020
Q4 | $3.29M | Buy |
103,300
+2,300
| +2% | +$60.4K | 0.01% | 1104 |
|
|
2020
Q3 | $2.59M | Buy |
101,000
+9,400
| +10% | +$214K | 0.01% | 1116 |
|
|
2020
Q2 | $2.35M | Buy |
91,600
+10,300
| +13% | +$209K | 0.01% | 1094 |
|
|
2020
Q1 | $1.25M | Buy |
81,300
+16,400
| +25% | +$356K | ﹤0.01% | 1158 |
|
|
2019
Q4 | $2.23M | Hold |
64,900
| – | – | 0.01% | 1123 |
|
|
2019
Q3 | $485K | Hold |
64,900
| – | – | ﹤0.01% | 1341 |
|
|
2019
Q2 | $842K | Buy |
64,900
+5,000
| +8% | +$64.1K | ﹤0.01% | 1185 |
|
|
2019
Q1 | $730K | Buy |
59,900
+13,700
| +30% | +$175K | ﹤0.01% | 1238 |
|
|
2018
Q4 | $526K | Buy |
46,200
+600
| +1% | +$9.69K | ﹤0.01% | 1298 |
|
|
2018
Q3 | $990K | Hold |
45,600
| – | – | ﹤0.01% | 1220 |
|
|
2018
Q2 | $806K | Buy |
45,600
+21,600
| +90% | +$439K | ﹤0.01% | 1243 |
|
|
2018
Q1 | $505K | Hold |
24,000
| – | – | ﹤0.01% | 1300 |
|
|
2017
Q4 | $348K | Hold |
24,000
| – | – | ﹤0.01% | 1339 |
|
|
2017
Q3 | $379K | Hold |
24,000
| – | – | ﹤0.01% | 1348 |
|
|
2017
Q2 | $298K | Buy |
+24,000
| New | +$278K | ﹤0.01% | 1368 |
|
Other funds holding ITCI
KIM
HNB
State of Wisconsin Investment Board's ITCI Position: Q2 2025 in Review
State of Wisconsin Investment Board sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 163,290 shares — an estimated $21.5M sold.
State of Wisconsin Investment Board first reported a position in ITCI in Q2 2017 and held it in 32 quarters. The position peaked at $21.5M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- State of Wisconsin Investment Board reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- State of Wisconsin Investment Board sold 163,290 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $21.5M.
- State of Wisconsin Investment Board first reported a position in Intra-Cellular Therapies Inc. in Q2 2017 and held it in 32 quarters.
- State of Wisconsin Investment Board's Intra-Cellular Therapies Inc. position peaked at $21.5M in Q1 2025.
- 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on State of Wisconsin Investment Board's 13F filing for Q2 2025, filed 14 Aug 2025.